TY - JOUR T1 - Breast cancer screening and early diagnosis in Chinese women JF - Cancer Biology & Medicine JO - Cancer Biology & Medicine SP - 450 LP - 467 DO - 10.20892/j.issn.2095-3941.2021.0676 VL - 19 IS - 4 AU - Rui Ding AU - Yi Xiao AU - Miao Mo AU - Ying Zheng AU - Yi-Zhou Jiang AU - Zhi-Ming Shao Y1 - 2022/04/15 UR - http://www.cancerbiomed.org/content/19/4/450.abstract N2 - Breast cancer is the most common malignant tumor in Chinese women, and its incidence is increasing. Regular screening is an effective method for early tumor detection and improving patient prognosis. In this review, we analyze the epidemiological changes and risk factors associated with breast cancer in China and describe the establishment of a screening strategy suitable for Chinese women. Chinese patients with breast cancer tend to be younger than Western patients and to have denser breasts. Therefore, the age of initial screening in Chinese women should be earlier, and the importance of screening with a combination of ultrasound and mammography is stressed. Moreover, Chinese patients with breast cancers have several ancestry-specific genetic features, and aiding in the determination of genetic screening strategies for identifying high-risk populations. On the basis of current studies, we summarize the development of risk-stratified breast cancer screening guidelines for Chinese women and describe the significant improvement in the prognosis of patients with breast cancer in China. ER -